Glaxo Says It Will Stop Paying Doctors to Promote Drugs

The British drug maker GlaxoSmithKline will no longer pay doctors to promote its products and will stop tying compensation of sales representatives to the number of prescriptions doctors write, its chief executive said Monday, effectively ending two common industry practices that critics have long assailed as troublesome conflicts of interest.

The announcement appears to be a first for a major drug company — although others may be considering similar moves — and it comes at a particularly sensitive time for Glaxo. It is the subject of a bribery investigation in China, where authorities contend the company funneled illegal payments to doctors and government officials in an effort to lift drug sales.

Read more »

Advertisements

About lightsigns
Pointing my finger on the brighter spots. We win, and winning is fun.

Comments are closed.

%d bloggers like this: